This section of the COMPANY NAME InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  COMPANY NAME assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQTLMD
Beta(1.25)
Shares Outstanding101.3M
Average Volume (10 days)0
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.56)
Sales (TTM)$0.79
Book Value (MRQ)$1.65
Cash Flow (TTM)($0.44)
Cash (MRQ)$0.39

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy1
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Robert Jason Hallock
Chief Medical Officer
(6,491)
Sell
Apr 1, 2022
David Mikula
Chief Operating Officer
450,000
Acquire
Dec 20, 2021
Christopher M. Gallagher
Director
1,080,000
Acquire
Dec 20, 2021
Thomas J. Carella
Director
21,067
Acquire
Jun 3, 2021
Amr Kronfol
Director
21,067
Acquire
Jun 3, 2021

Recent SEC Filings

15-12B
Apr 18, 2022
EFFECT
Apr 8, 2022
EFFECT
Apr 8, 2022
Insider Buy/Sell
Apr 7, 2022
Insider Buy/Sell
Apr 7, 2022